 |
NYON, Switzerland, March 4, 2021 /PRNewswire/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sustained limus release DEB catheter, in the...
Two years ago, I entered the digital marketing space with the mindset of an engineering student and the work ethic of a h...
Australian small businesses are being hit harder than ever by costly disruptions, with new data by leading...
Half of Australians now pay only for their own order and one in three are ditching the shout A widening gap in what Austra...
Two years ago, I entered the digital marketing space with the mindset of an engineering student ...
Australian small businesses are being hit harder than ever by costly disruptions...
McDonald’s Australia is once again rolling up its sleeves for Clean Up Australia Day, marking 36...
Iftar returns to IFTAR, with the Western Sydney favourite opening after dark for Ramadan IFTA...
Depression is a complex and deeply personal experience. While almost everyone has periods of s...
We are at the end of the great Australian summer, and this is the perfect time to start thinking a...
The reality is, owning a home isn’t for everyone. It’s a personal lifestyle decision rather than a...
Kmart’s fresh new February Living range brings affordable style to every room, showcasing an insp...
Data collected by Holafly found that 8 in 10 professionals plan to travel internationally in 202...